0 items USD 0.00Search
- Did you mean
- system fibrosis drug
Your search for "Systemic sclerosis drug" gave back 497925 results.
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig鈥檚 disease or Maladie De Charcot, it is a neurological disease that causes nerve cells...
颁补迟补濒辞驳:听
MRRPB5
February 2023
Price: USD 2,900.00
The global Tysabri market size was valued at US$ 1986.7 million in 2023. With growing demand in downstream market, the Tysabri is forecast to a...
颁补迟补濒辞驳:听
LPI
March 2024
Price: USD 3,660.00
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig鈥檚 disease or Maladie De Charcot, it is a neurological disease that causes nerve cells...
颁补迟补濒辞驳:听
MRRPB5
February 2023
Price: USD 2,900.00
Cladribine drugs are a synthetic purine nucleoside analog of deoxyadenosine used primarily in oncology to treat certain hematologic cancers, such as...
颁补迟补濒辞驳:听
LPI
October 2024
Price: USD 3,660.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 3,950.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 3,950.00
Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Pipeline Review, H2 2018 Summary Estrogen...
颁补迟补濒辞驳:听
Global Markets Direct
September 2018
Price: USD 3,500.00
The global Nervous System Markers market size was valued at US$ 583 million in 2024 and is forecast to a readjusted size of USD 871 million by 2031...
颁补迟补濒辞驳:听
GIR
May 2025
Price: USD 3,480.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
颁补迟补濒辞驳:听
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
颁补迟补濒辞驳:听
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
颁补迟补濒辞驳:听
MRRPB5
January 2024
Price: USD 2,900.00
T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H2 2018 Summary T Cell...
颁补迟补濒辞驳:听
Global Markets Direct
August 2018
Price: USD 3,500.00
According to this study, the global Specialty Drug Distribution market size will reach US$ 654973 million by 2031. Specialty distributor handle...
颁补迟补濒辞驳:听
LPI
August 2025
Price: USD 3,660.00
BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B...
颁补迟补濒辞驳:听
Global Markets Direct
April 2019
Price: USD 3,500.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 3,950.00
听
